Quantitative Research

Take smarter tactical investment decisions with Prisma.

Our research fuels scientific progress across industries, healthcare, and academia.
View Research Achievements
Startup template
/ Research

Research Expertise Across Key Scientific Domains

Biotech template
Life Sciences & Biotech
We support biotech teams and life science innovators with experimental design, assay validation, and product development consulting
Startup template
Environmental & Sustainability Research
Our team advises on testing strategies, regulatory pathways, and data generation to support green technologies and environmental impact studies
Laboratory & research template
Clinical Trials & Pharma Studies
From preclinical planning to regulatory documentation, we help pharma teams streamline trial design, testing, and lab collaboration
Biotech template
Materials & Industrial Research
We guide R&D and engineering teams through material testing, durability validation, and performance analysis in lab-controlled environments.
No items found.
No items found.
testimonials

Trusted by Leading Asset Managers

/ 01
We chose Finlens for its modern design and interactivity, which greatly enhance the client experience and set it apart from other solutions. The team is highly responsive and flexible, consistently providing effective solutions to challenges that arise.
Bilal Jusufi
Partner at Lakefield Partners AG
/ 02
Finlens revolutionizes our factsheet production by automating processes, reducing errors, and saving valuable time, allowing our team to focus on higher value activities. Its intuitive drag-and-drop tools make customization effortless, combining automation with flexibility.
Adi Wenzel
CIO at SSI Asset Management AG
/ 03
It is a real pleasure working with Alquant, everything always as promised and on time. Our clients can now follow our fund partners with integrated live pricing on our webpage, a real value add.
Stephan Meier
CEO at Open Funds Investment Services
/ 04
Automating processes and maintaining a professional & polished appearance are key for growing AuM, especially for small to mid-sized asset managers. Finlens excels in addressing these crucial aspects. I highly recommend it to any asset manager.
Vincent Bonnard
Founding Partner at FINANZLAB
/ 05
Switching to Finlens has been a great decision , it offers superior flexibility, customization, and cost-effectiveness compared to our previous provider. The Alquant team is highly responsive, quickly adapting solutions to our needs, while continuously adding new features that enhance our experience.
Sandro Francioni
Founder & CEO at FALGOM AG
Get Started

Bring flexibility and foresight to your investment process

Don’t let static allocations limit performance. Let Prisma guide your tactical allocation.
Static allocations are simple, disciplined flexibility is smarter. That’s what Prisma delivers.
Quang Pham
CIO & Co-Founder